2008 publications supported by the Fungal Research Trust directly or indirectly

Rosa DD, Pasqualotto AC, Denning DW. Chronic mucocutaneous candidiasis and oesophageal cancer. Med Mycol 2008;46:85-91.

Arendrup MC, Perkhofer S, Howard SJ, Perlin D, Latgè JP, Lass-Flörl C. In vivo confirmation of in vitro loss of susceptibility against caspofungin and azoles in clinical Aspergillus fumigatus isolates. Antimicrob Ag Chemother 2008;52:3504-11.

Pasqualotto AC, Denning DW. An aspergilloma caused by Aspergillus flavus. Med Mycol 2008;46:275-8.

Pasqualotto AC, Denning DW. New and emerging treatments for fungal infection. J Antimicrob Chemother 2008; 61(Suppl 1); i19-i30.

Carvalho A, Pasqualotto AC, Romani L, Denning DW, Rodrigues F. Polymorphisms in Toll-like receptors (TLR) genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008;197:618-621.

Pasqualotto AC, Shah M, Wynn R, Denning DW. Voriconazole plasma monitoring. Arch Dis Child 2008;93:578-81.

The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) (Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Denning DW, Fegeler W, Gaustad P, Lass-Flörl C, Moore CB, Richardson M, Schmalreck A, Velegraki A, Verweij P). EUCAST Technical Note on fluconazole. Clin Microbiol Infect 2008;14:193-195.

Rashid R, Pasquallotto AC, Denning DW. A case of spotted fever group rickettsiosis imported into the United Kingdom and treated with ciprofloxacin: a case report. J Med Case Reports 2008;2:98.

Federova N, Khaldi N, Joardar V, Maiti R, Amedeo, Anderson MJ, Crabtree J, Badger J, Albarraq A, Angiuoli S, Bussey H, Bowyer P, Cotty PJ, Dyer P, Egan A, Galens K, Fraser C, Haas B, Inman J, Kent, Lemieux S, Malavazi I, Orvis J, Roemer T, Ronning C, Silva J, Sundaram J, Sutton G, Turner G, Venter JC, White OR, Whitty B, Youngman P, Wolfe K, Goldman GH, Wortman JR, Jiang B, Denning DW, Nierman WC. Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet 2008;4:e1000046.

Rodriguez-Tudela JL, Arendrup M, Chryssanthou E, Dannaoui E, Denning DW, Donnelly JP, Schmalrek A, Verweij PE, Cuenca-Estrella M. Minimal inhibitory concentration distributions and epidemiological cut-offs of amphotericin B, flucytosine, fluconazole, itraconazole and voriconazole for Candida spp. using the EUCAST methodology for susceptibility testing. Clin Microbiol Infect 2008;14:982-4.

Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Denning DW, Fegeler W, Gaustad P, Klimko N, Lass-Florl C, Moore CB, Richardson M, Schmalreck A, Stenderup J, Velegraki A, Verweij P, and Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008; 14: 982-984.

Hope WW, Billaud EM, Lestner J, Denning DW. Therapeutic drug monitoring for triazoles. Curr Op Infect Dis 2008; 21: 580-86.

Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, MD, Bøe Wolff A, Husebye H, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning DW, Costigan C, Dominguez M, McConnell V, Willcox N, Meager A. Autoantibodies against type I Interferons: alternative diagnostic criteria for Auto-immune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). J Clin Endocrinol Metab 2008;93:4389-97.

Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning DW, McConnell V, Cant AJ, Abinun M, Spickett GP, Lilic D. Impaired Dendtritic Cell Maturation and Cytokine Production in Patients with Chronic Mucocutanous Candidiasis with or without APECED. Clin Exp Immunol 2008;154:406-14.

Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol 2008 Jul 25:1-10.